Interleukin-4 and Interleukin-13 signaling

No Pathway Network information available for Interleukin-4 and Interleukin-13 signaling

Ordered by rank within the SuperPath, via the multiplicity of each gene in the constituent pathways

Disorders associated with Interleukin-4 and Interleukin-13 signaling SuperPath

according to GeneCards Suite gene sharing
#DisorderTypeGenesScore
1Breast implant-associated anaplastic large cell lymphomaEnrichmentJAK1, JAK2, STAT36.33
2High-grade b-cell lymphoma double-hit/triple-hitEnrichmentBCL2, BCL6, MYC6.33
3Diffuse large b-cell lymphomaEnrichmentFOXO1, SOCS1, STAT3, TP534.90
4Intravascular large b-cell lymphomaEnrichmentBCL2, BCL64.22
5AsthmaEnrichmentALOX5, CCL11, IL134.14
6Human immunodeficiency virus type 1EnrichmentCCL11, CCL2, IL103.46
7Cerebral malariaEnrichmentCD36, ICAM13.44
8Behcet syndromeEnrichmentIL10, IL12A, IL23R3.39
9Rhabdomyosarcoma 2EnrichmentFOXO1, TP533.22
10Follicular lymphomaEnrichmentBCL2, BCL63.22
11Histiocytoid hemangiomaEnrichmentFOS, VIM3.22
12MalariaEnrichmentCD36, ICAM1, NOS23.13
13Chronic mucocutaneous candidiasisEnrichmentIL17F, STAT13.05
14Il10-related early-onset inflammatory bowel diseaseEnrichmentIL10, TGFB13.05
15Breast adenocarcinomaEnrichmentAKT1, TP533.05
16Essential thrombocythemiaEnrichmentJAK2, TP532.91
17Leukemia, chronic lymphocyticEnrichmentCCND1, TP532.58
18Systemic lupus erythematosusEnrichmentIL10, ITGAM, SOCS12.46
19Colorectal cancerEnrichmentAKT1, CCND1, PIK3R1, TP532.32
20Proteus syndromeEnrichmentAKT12.11
21Ehlers-danlos syndrome, cardiac valvular typeEnrichmentCOL1A22.11
22Systemic lupus erythematosus 6EnrichmentITGAM2.11
23Immunodeficiency 35EnrichmentTYK22.11
24Coronary heart disease 7EnrichmentCD362.11
25Skin/hair/eye pigmentation, variation in, 8EnrichmentIRF42.11
26Deafness, autosomal recessive 39EnrichmentHGF2.11
27Tubulointerstitial kidney disease, autosomal dominant 2EnrichmentMUC12.11
28Dermatitis, atopic, 4EnrichmentSOCS32.11
29Candidiasis, familial, 6EnrichmentIL17F2.11
30Nephrotic syndrome, type 26EnrichmentLAMA52.11
31Hyper-ige syndrome 6, autosomal dominant, with recurrent infectionsEnrichmentSTAT62.11
32Immunodeficiency 131EnrichmentIRF42.11
33Short syndromeEnrichmentPIK3R12.11
34Bone marrow failure syndrome 5EnrichmentTP532.11
35Combined osteogenesis imperfecta and ehlers-danlos syndrome 2EnrichmentCOL1A22.11
36Graft-versus-host diseaseEnrichmentIL102.11
37Papilloma of choroid plexusEnrichmentTP532.11
38Basal cell carcinoma 7EnrichmentTP532.11
39Brunner syndromeEnrichmentMAOA2.11
40Anaplastic thyroid carcinomaEnrichmentTP532.11
41T-cell large granular lymphocyte leukemiaEnrichmentSTAT32.11
42Allergic rhinitisEnrichmentIL132.11
43Immunodeficiency 42EnrichmentRORC2.11
44Microvascular complications of diabetes 1EnrichmentVEGFA2.11
45Psoriasis 7EnrichmentIL23R2.11
46Platelet glycoprotein iv deficiencyEnrichmentCD362.11
47Coronary heart disease 6EnrichmentMMP32.11
48Interleukin 6, serum level of, quantitative trait locusEnrichmentIL6R2.11
49Immunodeficiency 31aEnrichmentSTAT12.11
50Soluble interleukin-6 receptor, serum level of, quantitative trait locusEnrichmentIL6R2.11
51Immunodeficiency 36 with lymphoproliferationEnrichmentPIK3R12.11
52Immunodeficiency 29EnrichmentIL12B2.11
53Cowden syndrome 6EnrichmentAKT12.11
54Hyper-ige syndrome 5, autosomal recessive, with recurrent infectionsEnrichmentIL6R2.11
55Agammaglobulinemia 7, autosomal recessiveEnrichmentPIK3R12.11
56Inflammatory bowel disease 17EnrichmentIL23R2.11
57Immunodeficiency 31bEnrichmentSTAT12.11
58Factor xiii, a subunit, deficiency ofEnrichmentF13A12.11
59Ductal carcinoma in situEnrichmentTP532.11
60Heme oxygenase 1 deficiencyEnrichmentHMOX12.11
61Autoimmune disease, multisystem, infantile-onset, 1EnrichmentSTAT32.11
62Bent bone dysplasia syndrome 2EnrichmentLAMA52.11
63Serum amyloid a amyloidosisEnrichmentSAA12.11
64Thyroid gland undifferentiated carcinomaEnrichmentTP532.11
65Small-cell carcinoma of the ovary of hypercalcemic typeEnrichmentTP532.11
66T-b+ severe combined immunodeficiency due to jak3 deficiencyEnrichmentJAK32.11
67Diffuse pediatric-type high-grade glioma, h3-wildtype and idh-wildtypeEnrichmentTP532.11
68Stat3-related early-onset multisystem autoimmune diseaseEnrichmentSTAT32.11
69Choroid plexus cancerEnrichmentTP532.11
70AtherosclerosisEnrichmentALOX52.11
71Pleomorphic xanthoastrocytomaEnrichmentTP532.11
72Whipple diseaseEnrichmentIRF42.11
73Premature agingEnrichmentVIM2.11
74Lama5-related multisystemic syndromeEnrichmentLAMA52.11
75Chronic lymphoproliferative disorder of natural killer cellsEnrichmentSTAT32.11
76Mendelian susceptibility to mycobacterial diseases due to partial jak1 deficiencyEnrichmentJAK12.11
77Leukocyte adhesion deficiency, type iEnrichmentITGB21.81
78Burkitt lymphomaEnrichmentMYC1.81
79Hypoparathyroidism, sensorineural deafness, and renal dysplasia syndromeEnrichmentGATA31.81
80Adrenocortical carcinoma, hereditaryEnrichmentTP531.81
81Camurati-engelmann disease 1EnrichmentTGFB11.81
82Spondyloepimetaphyseal dysplasia, strudwick typeEnrichmentFN11.81
83Spondylometaphyseal dysplasia, corner fracture typeEnrichmentFN11.81
84Hemangiopericytoma, malignantEnrichmentSTAT61.81
85Bruck syndrome 1EnrichmentCOL1A21.81
86Robinow-sorauf syndromeEnrichmentTWIST11.81
87Cervical cancerEnrichmentTP531.81
88Leukocyte adhesion deficiency, type iiiEnrichmentITGB21.81
89Lymphoma, hodgkin, classicEnrichmentTP531.81
90Thrombocythemia 3EnrichmentJAK21.81
91Immunodeficiency 31cEnrichmentSTAT11.81
92Sweeney-cox syndromeEnrichmentTWIST11.81
93Ehlers-danlos syndrome, arthrochalasia type, 2EnrichmentCOL1A21.81
94Inflammatory bowel disease, immunodeficiency, and encephalopathyEnrichmentTGFB11.81
95Recessive dystrophic epidermolysis bullosaEnrichmentMMP11.81
96Cataract 30EnrichmentVIM1.81
97Camurati-engelmann diseaseEnrichmentTGFB11.81
98Congenital fibrosarcomaEnrichmentTP531.81
99Metaphyseal anadysplasia 2EnrichmentMMP91.81
100Li-fraumeni syndrome 1EnrichmentTP531.81
101SarcomaEnrichmentTP531.81
102Autoinflammation, immune dysregulation, and eosinophiliaEnrichmentJAK11.81
103Cervix carcinomaEnrichmentTP531.81
104Hodgkin's lymphomaEnrichmentTP531.81
105B-lymphoblastic leukemia/lymphoma with hyperdiploidyEnrichmentGATA31.81
106Hypoparathyroidism-deafness-renal disease syndromeEnrichmentGATA31.81
107Intellectual developmental disorder with or without epilepsy or cerebellar ataxiaEnrichmentRORA1.81
108PolycythemiaEnrichmentJAK21.81
109Metaphyseal anadysplasiaEnrichmentMMP91.81
110Lymphomatoid papulosisEnrichmentTYK21.81
111Ehlers-danlos/osteogenesis imperfecta syndromeEnrichmentCOL1A21.81
112Autosomal dominant nonsyndromic deafnessEnrichmentGATA31.81
113Hypereosinophilic syndromeEnrichmentJAK21.81
114Dentinogenesis imperfectaEnrichmentCOL1A21.81
115Primary mediastinal large b-cell lymphomaEnrichmentBCL61.81
116Non-syndromic sagittal craniosynostosisEnrichmentTWIST11.81
117Factor xiii deficiencyEnrichmentF13A11.81
118Pleomorphic rhabdomyosarcomaEnrichmentTP531.81
119Primary cutaneous anaplastic large cell lymphomaEnrichmentTYK21.81
120Bladder cancerEnrichmentCDKN1A, TP531.67
121Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-negative, due to adenosine deaminase deficiencyEnrichmentJAK31.63
122Hyper-ige syndrome 1, autosomal dominant, with recurrent infectionsEnrichmentSTAT31.63
123Craniosynostosis 1EnrichmentTWIST11.63
124Immune thrombocytopeniaEnrichmentSOCS11.63
125Takayasu arteritisEnrichmentIL12B1.63
126Polycythemia veraEnrichmentJAK21.63
127Mycosis fungoidesEnrichmentTNFRSF1B1.63
128Severe combined immunodeficiency, x-linkedEnrichmentIL2RG1.63
129Glomerulopathy with fibronectin deposits 2EnrichmentFN11.63
130Obesity, early-onset, with adrenal insufficiency and red hairEnrichmentPOMC1.63
131Multicentric osteolysis, nodulosis, and arthropathyEnrichmentMMP21.63
132Osteogenic sarcomaEnrichmentTP531.63
133Combined immunodeficiency, x-linkedEnrichmentIL2RG1.63
134Corneal dystrophy, posterior polymorphous, 3EnrichmentZEB11.63
135Corneal dystrophy, fuchs endothelial, 6EnrichmentZEB11.63
136Nasopharyngeal carcinomaEnrichmentTP531.63
137Congenital lipomatous overgrowth, vascular malformations, and epidermal neviEnrichmentPIK3R11.63
138Immunodeficiency 14a with lymphoproliferation, autosomal dominantEnrichmentPIK3R11.63
139Autoinflammatory syndrome, familial, with or without immunodeficiencyEnrichmentSOCS11.63
140Hyper ige syndromeEnrichmentSTAT31.63
141Atypical teratoid rhabdoid tumorEnrichmentTP531.63
142Anaplastic astrocytomaEnrichmentTP531.63
143Immunodeficiency 14EnrichmentPIK3R11.63
144Squamous cell carcinomaEnrichmentTP531.63
145AdenocarcinomaEnrichmentTP531.63
146Intraocular pressure quantitative trait locusEnrichmentZEB11.63
147End stage renal diseaseEnrichmentGATA31.63
148Bone osteosarcomaEnrichmentTP531.63
149High bone mass osteogenesis imperfectaEnrichmentCOL1A21.63
150EnchondromatosisEnrichmentHIF1A1.63
151Obesity due to pro-opiomelanocortin deficiencyEnrichmentPOMC1.63
152Saczary syndromeEnrichmentTNFRSF1B1.63
153Cystic fibrosisEnrichmentHMOX1, TGFB11.59
154Kaposi sarcomaEnrichmentIL61.51
155Ehlers-danlos syndrome, arthrochalasia type, 1EnrichmentCOL1A21.51
156Erythrocytosis, familial, 1EnrichmentJAK21.51
157Small cell cancer of the lungEnrichmentTP531.51
158Anemia, autoimmune hemolyticEnrichmentSOCS11.51
159Microphthalmia, syndromic 3EnrichmentSOX21.51
160Thyroid cancer, nonmedullary, 1EnrichmentTP531.51
161Budd-chiari syndromeEnrichmentJAK21.51
162Saethre-chotzen syndromeEnrichmentTWIST11.51
163Schaaf-yang syndromeEnrichmentNDN1.51
164Congenital generalized lipodystrophyEnrichmentFOS1.51
165Mantle cell lymphomaEnrichmentCCND11.51
166Lung sarcomatoid carcinomaEnrichmentTP531.51
167Embryonal rhabdomyosarcomaEnrichmentTP531.51
168Blood platelet diseaseEnrichmentCD361.51
169Corneal dystrophyEnrichmentZEB11.51
170Adenosine deaminase deficiencyEnrichmentJAK31.51
171Osteogenesis imperfecta with normal sclerae, dominant formEnrichmentCOL1A21.51
172Non-syndromic bicoronal craniosynostosisEnrichmentTWIST11.51
173Systemic-onset juvenile idiopathic arthritisEnrichmentIL61.51
174Enchondromatosis, multiple, ollier typeEnrichmentHIF1A1.41
175Von hippel-lindau syndromeEnrichmentCCND11.41
176Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-negativeEnrichmentJAK31.41
177Rheumatoid arthritis, systemic juvenileEnrichmentIL61.41
178Fuchs' endothelial dystrophyEnrichmentZEB11.41
179LymphomaEnrichmentTP531.41
180Myeloproliferative neoplasmEnrichmentJAK21.41
181Acute megakaryocytic leukemiaEnrichmentTP531.41
182Leukemia, acute myeloidEnrichmentJAK2, TP531.41
183Gastric cancerEnrichmentIL1B, TP531.35
184Nephrotic syndromeEnrichmentFN1, LAMA51.35
185Ehlers-danlos syndrome, classic type, 1EnrichmentCOL1A21.34
186Li-fraumeni syndromeEnrichmentTP531.34
187Osteogenesis imperfecta, type iEnrichmentCOL1A21.34
188Corneal dystrophy, posterior polymorphous, 1EnrichmentZEB11.34
189Type 1 diabetes mellitusEnrichmentIL61.34
190Inflammatory bowel disease 25, autosomal recessiveEnrichmentTGFB11.34
191Adrenocortical carcinomaEnrichmentTP531.34
192Classic ehlers-danlos syndromeEnrichmentCOL1A21.34
193Hereditary breast carcinomaEnrichmentAKT1, TP531.33
194Esophageal cancerEnrichmentTP531.27
195Prader-willi syndromeEnrichmentNDN1.27
196Multiple endocrine neoplasia, type iEnrichmentCDKN1A1.27
197Osteogenesis imperfecta, type iiEnrichmentCOL1A21.27
198Thrombophilia due to thrombin defectEnrichmentF13A11.27
199MyelofibrosisEnrichmentJAK21.27
200Squamous cell carcinoma, head and neckEnrichmentTP531.27
201Multiple enchondromatosis, maffucci typeEnrichmentHIF1A1.27
202Gallbladder cancerEnrichmentTP531.27
203Overgrowth syndromeEnrichmentPIK3R11.27
204B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)EnrichmentTP531.27
205Glioma susceptibility 1EnrichmentTP531.22
206Lymphoma, non-hodgkin, familialEnrichmentTP531.22
207Permanent neonatal diabetes mellitusEnrichmentSTAT31.22
208Rheumatoid arthritisEnrichmentIL101.17
209Inflammatory bowel disease 1EnrichmentIL61.17
210Leukemia, acute lymphoblastic 3EnrichmentJAK21.17
211Adult hepatocellular carcinomaEnrichmentTP531.17
212Primary hyperaldosteronismEnrichmentTP531.17
213Primary biliary cholangitisEnrichmentIL12A1.17
214Cowden syndromeEnrichmentAKT11.17
215Myeloma, multipleEnrichmentCCND1, TP531.15
216Cataract 30, multiple typesEnrichmentVIM1.12
217Omenn syndromeEnrichmentIL2RG1.12
218Familial colorectal cancerEnrichmentTP531.12
219Autosomal non-syndromic agammaglobulinemiaEnrichmentPIK3R11.12
220Primary bone dysplasiaEnrichmentCOL1A21.12
221Myelodysplastic syndromeEnrichmentTP531.08
222NanophthalmosEnrichmentSOX21.08
223Combined immunodeficiencyEnrichmentIL2RG1.08
224OsteochondrodysplasiaEnrichmentCOL1A21.08
225Combined t cell and b cell immunodeficiencyEnrichmentIL2RG1.08
226Combined t and b cell immunodeficiencyEnrichmentIL2RG1.08
227Presynaptic congenital myasthenic syndromesEnrichmentLAMA51.08
228Septooptic dysplasiaEnrichmentSOX21.05
229MeningiomaEnrichmentAKT11.05
230Lip and oral cavity carcinomaEnrichmentTP531.05
231Osteogenesis imperfecta, type ivEnrichmentCOL1A21.01
232Neural tube defectsEnrichmentITGB11.01
233Pulmonary disease, chronic obstructiveEnrichmentHMOX11.01
234Acute promyelocytic leukemiaEnrichmentSTAT31.01
235Nk-cell enteropathyEnrichmentJAK31.01
236Multiple sclerosisEnrichmentLAMA50.98
237OsteoporosisEnrichmentCOL1A20.98
238Lung cancer susceptibility 3EnrichmentTP530.98
239Osteogenesis imperfecta, type iiiEnrichmentCOL1A20.95
240Breast cancerEnrichmentAKT1, TP530.93
241RhabdomyosarcomaEnrichmentTP530.93
242GliosarcomaEnrichmentTP530.93
243Giant cell glioblastomaEnrichmentTP530.90
244Arteriovenous malformations of the brainEnrichmentIL60.86
245Ehlers-danlos syndromeEnrichmentCOL1A20.86
246Macs syndromeEnrichmentSOX20.84
247HepatoblastomaEnrichmentTP530.82
248Hepatocellular carcinomaEnrichmentTP530.80
249Myocardial infarctionEnrichmentF13A10.80
250MicrophthalmiaEnrichmentSOX20.80
251Diamond-blackfan anemia 1EnrichmentTP530.78
252Brittle bone disorderEnrichmentCOL1A20.78
253Precursor t-cell acute lymphoblastic leukemiaEnrichmentMYC0.78
254Pancreatic cancerEnrichmentTP530.75
255Ovarian cancerEnrichmentAKT1, TP530.73
256Prostate cancerEnrichmentTP530.69
257Severe covid-19EnrichmentJAK30.69
258Severe combined immunodeficiencyEnrichmentJAK30.64
259CakutEnrichmentGATA30.63
260Genetic steroid-resistant nephrotic syndromeEnrichmentLAMA50.63
261Diamond-blackfan anemiaEnrichmentTP530.61
262Type 2 diabetes mellitusEnrichmentIL60.55
263Sensorineural hearing lossEnrichmentHGF0.50
264Body mass index quantitative trait locus 11EnrichmentPOMC0.49
265Hereditary breast ovarian cancer syndromeEnrichmentTP530.45
266Primary ovarian insufficiencyEnrichmentJAK20.43
267Rare autosomal recessive non-syndromic sensorineural deafness type dfnbEnrichmentHGF0.30
268Complex neurodevelopmental disorderEnrichmentRORA0.21
269Inherited cancer-predisposing syndromeEnrichmentTP530.19

Loading...
Loading...
Loading...